Oxaliplatin induced-neuropathy in digestive tumors
M Sereno, G Gutiérrez-Gutiérrez… - Critical reviews in …, 2014 - Elsevier
M Sereno, G Gutiérrez-Gutiérrez, C Gómez-Raposo, M López-Gómez, M Merino-Salvador…
Critical reviews in oncology/hematology, 2014•ElsevierOxaliplatin is one of the main drugs used in digestive tumors treatment. Peripheral
neuropathy is a well-recognized dose-limiting toxicity of OXL. Two types of neuropathy have
been described with this agent: acute or transient and chronic or persistent, with different
etiology, clinical manifestations and prognosis. This paper is an exhaustive review about the
main aspects of oxaliplatin induced peripheral neuropathy, focus in clinical features,
treatment, prevention strategies and future approach.
neuropathy is a well-recognized dose-limiting toxicity of OXL. Two types of neuropathy have
been described with this agent: acute or transient and chronic or persistent, with different
etiology, clinical manifestations and prognosis. This paper is an exhaustive review about the
main aspects of oxaliplatin induced peripheral neuropathy, focus in clinical features,
treatment, prevention strategies and future approach.
Abstract
Oxaliplatin is one of the main drugs used in digestive tumors treatment. Peripheral neuropathy is a well-recognized dose-limiting toxicity of OXL. Two types of neuropathy have been described with this agent: acute or transient and chronic or persistent, with different etiology, clinical manifestations and prognosis.
This paper is an exhaustive review about the main aspects of oxaliplatin induced peripheral neuropathy, focus in clinical features, treatment, prevention strategies and future approach.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果